Ovarian cancer screening and mortality

JAMA

Volumn 306, Issue 14, 2011, Pages 1544-

  Menon, Usha ^a   Gentry Maharaj, Aleksandra ^a   Jacobs, Ian ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

ANTIGEN DETECTION; CANCER MORTALITY; CANCER SCREENING; DIAGNOSTIC ACCURACY; HUMAN; LETTER; OVARY CANCER; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; ULTRASOUND; BLOOD; ECHOGRAPHY; FEMALE; MASS SCREENING; METHODOLOGY; MORTALITY; NOTE; OVARY TUMOR;

CA-125 ANTIGEN; FEMALE; HUMANS; MASS SCREENING; OVARIAN NEOPLASMS;

EID: 80054003601     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.1461     Document Type: Letter

References (5)

1. Buys SS, Partridge E, Black A, et al; PLCO Project Team. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA. 2011;305(22):2295-2303.
2. Skates SJ, Menon U,MacDonald N, et al. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women. J Clin Oncol. 2003;21(10 suppl):206s-210s.
3. Menon U, Skates SJ, Lewis S, et al. Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer. J Clin Oncol. 2005;23(31):7919-7926. (Pubitemid 46657391)
4. Menon U, Gentry-Maharaj A, Hallett R, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009;10(4):327-340.
5. International Agency for Research on Cancer. Effectiveness of Screening in Populations: IARC Handbook of Cancer Prevention. Vol 10. Lyon, France: IARC Press; 2005:201-225.